• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
COH
Click for more information
0.14% $305.86

COCHLEAR LIMITED - Announcements

Market Cap $18.63B  ! watchlist Created with Sketch. Add to my watchlist

Cochlear Limited is an Australia-based company, which provides implantable hearing... Cochlear Limited is an Australia-based company, which provides implantable hearing solutions and sound processors. The Company is engaged in development, manufacture and commercialization of implantable hearing solutions. Its segments include Cochlear implants, Services (sound processor upgrades and other) and Acoustics. The Company’s products and services portfolio include Cochlear implant portfolio, Acoustic solutions portfolio, and Recipient support tools. Its Cochlear Connected Care solutions include Cochlear Nucleus SmartNav System, Cochlear Custom Sound Pro Fitting Software, Cochlear Link, Cochlear Remote Assist, and Cochlear Remote Check solution for cochlear implants. Its Cochlear implant portfolio include Cochlear Nucleus System. Its Acoustic solutions portfolio include Cochlear Osia System, and Cochlear Baha System. Its Recipient support tools include Cochlear Nucleus, Baha and Osia Smart Apps and Cochlear CoPilot App.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
COHChange in substantial holding21/07/10
COHChange in substantial holding13/07/10
COHFinal Director's Interest Notice - Tommie Bergman06/07/10
COHSettlement Agreement with the DOJ and OIGPRICE SENSITIVE04/06/10
CBA +Ceasing to be a substantial holder from CBA28/05/10
COHChange in substantial holding11/05/10
COHResponse to ASX Price QueryPRICE SENSITIVE26/03/10
COHCochlear Ltd Announces Appointment of New Chairman17/03/10
COHCOH Half Yearly Report15/03/10
COHAppendix 3B05/03/10
COHAppendix 3Y - Dr Chris Roberts04/03/10
COHAppendix 3B01/03/10
COHChange of Director's Interest Notice - Dr Chris Roberts24/02/10
COHAppendix 3B22/02/10
COHAppendix 3B19/02/10
COHAppendix 3B17/02/10
COHAppendix 3B - Replacement15/02/10
COHAppendix 3B15/02/10
COHCeasing to be a substantial holder11/02/10
COHReplacement Appendix 3B11/02/10
COHCOH Half Year Results Analyst Presentation 09.021009/02/10
COHCOH Half Year Results Media Release 09.02.1009/02/10
COHCOH Half Year Report as at 31 December 2009 09.02.10PRICE SENSITIVE09/02/10
COHBecoming a substantial holder14/12/09
COHChange of Director's Interest Notice - Dr Chris Roberts17/11/09
COHAppendix 3B17/11/09
COHBecoming a substantial holder from CBA13/11/09
COHAppendix 3B11/11/09
COHAppendix 3B09/11/09
COHAppendix 3B02/11/09
COHAppendix 3B26/10/09
COHChange of Director's Interest Notice - Dr Chris Roberts21/10/09
COHAppendix 3B - Options20/10/09
COHResults of Meeting - Cochlear Limited AGM 200920/10/09
COH20/10/09 Cochlear AGM Presentation to Shareholders20/10/09
COH20/10/09 Chairmans AGM Address to Shareholders20/10/09
COHChange of Director's Interest Notice - R Holliday-Smith09/10/09
COHAppendix 3B - CELTIP Performance Shares23/09/09
COHAppendix 3B - CELTIP Options23/09/09
COHReplacement Appendix 3B - 8 September 200923/09/09
COHChange of Director's Interest Notice - Dr Chris Roberts17/09/09
COHAnnual General Meeting - Chairman's Letter17/09/09
COHAnnual General Meeting - Proxy Form17/09/09
COHNotice of Annual General Meeting17/09/09
COHAnnual Report to shareholders - Financials16/09/09
COHAnnual Report to shareholders - Editorial16/09/09
COHChange in substantial holding15/09/09
COHTechnnology Purchase Towards a Totally Implantable CochlearPRICE SENSITIVE09/09/09
COHAppendix 3B08/09/09
COHAppendix 3B07/09/09
COHFDA Approval for Nucleus 5 SystemPRICE SENSITIVE04/09/09
COHAppendix 3B31/08/09
COHRevised Appendix 3B 17 August 200924/08/09
COHAppendix 3B24/08/09
COHAppendix 3B17/08/09
COHCOH Full Year Results Analyst Presentation 11.08.0911/08/09
COHAmendment to Independent Audit Report COH Appendix 4E11/08/09
COHCOH Full Year Results Media Release 11.08.0911/08/09
COHFull Year Statutory AccountsPRICE SENSITIVE11/08/09
COHCOH Market Update 14th July 2009PRICE SENSITIVE14/07/09
COHChange in substantial holding12/06/09
COHCOH Completes Debt Refinancing04/06/09
COHCOH concludes agreements for new global headquarters03/06/09
COHAward of new Cochlear Global Headquarters ConstructionPRICE SENSITIVE03/06/09
COHChange in substantial holding28/05/09
COHAppendix 3B21/04/09
COHCOH Half Year Report to Shareholders16/03/09
COHAppendix 3B10/03/09
COHAppendix 3B23/02/09
COHAppendix 3B16/02/09
COHCOH Half Year Results Analyst Presentation 10.02.0910/02/09
COHCOH Media Release Half Year Accounts 10.02.09PRICE SENSITIVE10/02/09
COHCOH Half Year Accounts Appendix 4D 10.02.09PRICE SENSITIVE10/02/09
COHChange in substantial holding
21/07/10
COHChange in substantial holding
13/07/10
COHFinal Director's Interest Notice - Tommie Bergman
06/07/10
COHSettlement Agreement with the DOJ and OIG
04/06/10PRICE SENSITIVE
CBA +Ceasing to be a substantial holder from CBA
28/05/10
COHChange in substantial holding
11/05/10
COHResponse to ASX Price Query
26/03/10PRICE SENSITIVE
COHCochlear Ltd Announces Appointment of New Chairman
17/03/10
COHCOH Half Yearly Report
15/03/10
COHAppendix 3B
05/03/10
COHAppendix 3Y - Dr Chris Roberts
04/03/10
COHAppendix 3B
01/03/10
COHChange of Director's Interest Notice - Dr Chris Roberts
24/02/10
COHAppendix 3B
22/02/10
COHAppendix 3B
19/02/10
COHAppendix 3B
17/02/10
COHAppendix 3B - Replacement
15/02/10
COHAppendix 3B
15/02/10
COHCeasing to be a substantial holder
11/02/10
COHReplacement Appendix 3B
11/02/10
COHCOH Half Year Results Analyst Presentation 09.0210
09/02/10
COHCOH Half Year Results Media Release 09.02.10
09/02/10
COHCOH Half Year Report as at 31 December 2009 09.02.10
09/02/10PRICE SENSITIVE
COHBecoming a substantial holder
14/12/09
COHChange of Director's Interest Notice - Dr Chris Roberts
17/11/09
COHAppendix 3B
17/11/09
COHBecoming a substantial holder from CBA
13/11/09
COHAppendix 3B
11/11/09
COHAppendix 3B
09/11/09
COHAppendix 3B
02/11/09
COHAppendix 3B
26/10/09
COHChange of Director's Interest Notice - Dr Chris Roberts
21/10/09
COHAppendix 3B - Options
20/10/09
COHResults of Meeting - Cochlear Limited AGM 2009
20/10/09
COH20/10/09 Cochlear AGM Presentation to Shareholders
20/10/09
COH20/10/09 Chairmans AGM Address to Shareholders
20/10/09
COHChange of Director's Interest Notice - R Holliday-Smith
09/10/09
COHAppendix 3B - CELTIP Performance Shares
23/09/09
COHAppendix 3B - CELTIP Options
23/09/09
COHReplacement Appendix 3B - 8 September 2009
23/09/09
COHChange of Director's Interest Notice - Dr Chris Roberts
17/09/09
COHAnnual General Meeting - Chairman's Letter
17/09/09
COHAnnual General Meeting - Proxy Form
17/09/09
COHNotice of Annual General Meeting
17/09/09
COHAnnual Report to shareholders - Financials
16/09/09
COHAnnual Report to shareholders - Editorial
16/09/09
COHChange in substantial holding
15/09/09
COHTechnnology Purchase Towards a Totally Implantable Cochlear
09/09/09PRICE SENSITIVE
COHAppendix 3B
08/09/09
COHAppendix 3B
07/09/09
COHFDA Approval for Nucleus 5 System
04/09/09PRICE SENSITIVE
COHAppendix 3B
31/08/09
COHRevised Appendix 3B 17 August 2009
24/08/09
COHAppendix 3B
24/08/09
COHAppendix 3B
17/08/09
COHCOH Full Year Results Analyst Presentation 11.08.09
11/08/09
COHAmendment to Independent Audit Report COH Appendix 4E
11/08/09
COHCOH Full Year Results Media Release 11.08.09
11/08/09
COHFull Year Statutory Accounts
11/08/09PRICE SENSITIVE
COHCOH Market Update 14th July 2009
14/07/09PRICE SENSITIVE
COHChange in substantial holding
12/06/09
COHCOH Completes Debt Refinancing
04/06/09
COHCOH concludes agreements for new global headquarters
03/06/09
COHAward of new Cochlear Global Headquarters Construction
03/06/09PRICE SENSITIVE
COHChange in substantial holding
28/05/09
COHAppendix 3B
21/04/09
COHCOH Half Year Report to Shareholders
16/03/09
COHAppendix 3B
10/03/09
COHAppendix 3B
23/02/09
COHAppendix 3B
16/02/09
COHCOH Half Year Results Analyst Presentation 10.02.09
10/02/09
COHCOH Media Release Half Year Accounts 10.02.09
10/02/09PRICE SENSITIVE
COHCOH Half Year Accounts Appendix 4D 10.02.09
10/02/09PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
$305.86 		Change
-0.420(0.14%) 		Mkt cap ! $18.63B
Open High Low Value Volume
$309.20 $309.20 $304.59 $37.45M 122.2K

Buyers (Bids)

No. Vol. Price($)
1 350 $305.73
 

Sellers (Offers)

Price($) Vol. No.
$305.86 150 1
View Market Depth
Last trade - 16.10pm 27/11/2024 (20 minute delay) ?
Last
$306.83 		  Change
-0.420 ( 0.14 %)
Open High Low Volume
$308.25 $308.39 $304.83 4419
Last updated 15.59pm 27/11/2024 ?
COH (ASX) Chart

Top Stories

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
ASX Market Open: Rising Aussie markets to ignore Wall Street's Thanksgiving caution | November 28, 2024 The ASX 200 seems to be ignoring a cautious Wall Street, expected to open 0.36% higher @ though things may change as U.S. trade wraps up.Investors in the States played it safe by taking profits before the Thanksgiving break.(A reminder: U.S. markets will be closed through Thursday for the holiday...
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.